Nicoletta Carlo-Stella

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source: LinkedIn

Nicoletta Carlo-Stella, MD, PhD, (b. 1966) is a rheumatologist with the Internal Medicine Department at a hospital in Pavia, Italy.[1][2]

She is one of the authors of the 2011 case definition, International Consensus Criteria.[3]

Studies[edit]

  • 2011, Excess of activating killer cell immunoglobulin‑like receptors and lack of HLA-Bw4 ligands: a two‑edged weapon in chronic fatigue syndrome.[4]
  • 2010, Letter to the editor re: "A formal analysis of cytokine networks in chronic fatigue syndrome" by Broderick et al.[5]
  • 2009, Demographic and clinical aspects of an Italian patient population with chronic fatigue syndrome.[6]
  • 2009, Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome.[7]
  • 2006, A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles.[8]

Talks and Interviews[edit]

Online presence[edit]

References[edit]

  1. https://it.linkedin.com/in/nicoletta-carlo-stella-b0044323
  2. http://prabook.com/web/person-view.html?profileId=157252
  3. Carruthers, BM; van de Sande, MI; De Meirleir, KL; Klimas, NG; Broderick, G; Mitchell, T; Staines, D; Powles, A C P; Speight, N; Vallings, R; Bateman, L; Baumgarten-Austrheim, B; Bell, DS; Carlo-Stella, N; Chia, J; Darragh, A; Jo, D; Lewis, D; Light, A; Marshall-Gradisnik, S; Mena, I; Mikovits, JA; Miwa, K; Murovska, M; Pall, ML; Stevens, S (2011), "Myalgic encephalomyelitis: International Consensus Criteria.", Journal of Internal Medicine, 270 (4): 327-38, PMID 21777306, doi:10.1111/j.1365-2796.2011.02428.x 
  4. Pasi, A; Bozzini, S; Carlo-Stella, N; Martinetti, M; Bombardieri, S; De Silvestri, A; Salvaneschi, L; Cuccia, M (2011), "Excess of activating killer cell immunoglobulin‑like receptors and lack of HLA-Bw4 ligands: a two‑edged weapon in chronic fatigue syndrome", Molecular Medicine Reports, 4 (3): 535-40, doi:10.3892/mmr.2011.447 
  5. Carlo-Stella N. (2010) Letter to the editor re: "A formal analysis of cytokine networks in chronic fatigue syndrome" by Broderick et al. Brain, Behavior, and Immunity, 24 (7):1218; author reply 1219. doi: 10.1016/j.bbi.2010.06.004. Epub 2010 Jun 16.Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20561580
  6. {{Citation | last1 = Carlo-Stella | first1 = N | authorlink1 = Nicoletta Carlo-Stella | last2 = Cuccia | first2 = M | authorlink2 = | title = Demographic and clinical aspects of an Italian patient population with chronic fatigue syndrome. | journal = Reumatismo | volume = 61 | issue = 4 | page = 285-9 | date = 2009 | pmid = | doi = 10.4081/reumatismo.2009.285
  7. Carlo-Stella, N; Bozzini, S; De Silvestri, A; Sbarsi, I; Pizzochero, C; Lorusso, L; Martinetti, M; Cuccia, M (2009), "Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome", International Journal of Immunopathology and Pharmacology, 22 (3): 745-54, PMID 19822091, doi:10.1177/039463200902200320 
  8. Carlo-Stella, N; Badulli, C; De Silvestri, A; Bazzichi, L; Martinetti, M; Lorusso, L; Bombardieri, S; Salvaneschi, L; Cuccia, M (2006), "A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles", Clinical and Experimental Rheumatology, 24 (2): 179-82, PMID 16762155 


The information provided at this site is not intended to diagnose or treat any illness.

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history